Amgen seeks to bolster drug pipeline with US$10.4b Onyx buy

Amgen struck a deal to buy cancer drug maker Onyx Pharmaceuticals for about US$10.4 billion, as it moves to restock its product pipeline in response to declining sales of its flagship anaemia drugs.

via Business feed http://www.scmp.com/business/companies/article/1299449/amgen-seeks-bolster-drug-pipeline-us104b-onyx-buy